Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

Agile Therapeutics Inc. (AGRX)

  • Technical Exchange News
  • April 23, 2024, 21:59 UTC
  • 39
  • 0 comments

Pink Current symbol attribute type Security_Name was changed. Previous value: -. New value: AGILE THERAPEUTICS INC.

Comment Full text

Veru Inc. (VERU)

  • Technical Exchange News
  • April 23, 2024, 19:06 UTC
  • 40
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Synaptogenix Inc (SNPX)

  • Technical Exchange News
  • April 23, 2024, 01:58 UTC
  • 44
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

DermTech Inc (DMTK)

  • Technical Exchange News
  • April 23, 2024, 01:58 UTC
  • 41
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Synaptogenix Inc (SNPX)

  • Technical Exchange News
  • April 22, 2024, 18:38 UTC
  • 40
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

DermTech Inc (DMTK)

  • Technical Exchange News
  • April 22, 2024, 18:37 UTC
  • 40
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Cullinan Oncology Inc (CGEM)

  • Technical Exchange News
  • April 22, 2024, 07:31 UTC
  • 43
  • 0 comments

NASDAQ symbol attribute type Security_Name was changed. Previous value: Cullinan Oncology, Inc. - Common Stock. New value: Cullinan Therapeutics, Inc. - Common Stock.

Comment Full text

Cullinan Oncology Inc (CGEM)

  • Technical Exchange News
  • April 22, 2024, 00:34 UTC
  • 45
  • 0 comments

NASDAQ traded attribute type Security_Name was changed. Previous value: Cullinan Oncology, Inc. - Common Stock. New value: Cullinan Therapeutics, Inc. - Common Stock.

Comment Full text

Cartesian Therapeutics Inc (RNAC)

  • Technical Exchange News
  • April 20, 2024, 02:01 UTC
  • 45
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Cartesian Therapeutics Inc (RNAC)

  • Technical Exchange News
  • April 19, 2024, 18:45 UTC
  • 42
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text
  • Previous
  • 978
  • 979
  • 980
  • 981
  • 982
  • Next

Search

News categories

  • Technical Exchange News(14604)
  • Event(6229)
  • SEC News(385338)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(235145)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin